Featured News

New research from Tampere University in Finland shows exciting progress in a new drug for celiac disease. This drug, ZED1227 could be used alongside a gluten-free diet to help manage…

Use the Power of Your Story to Advocate for Federal Funding and Awareness Join the Celiac Disease Foundation’s Congressional District Days from August 5 to September 6, 2024, and help…

On May 20 the Disease Foundation hosted its third annual award reception at Digestive Disease Week in Washington, D.C. From prestigious global research prizes to inaugural student and policy leadership awards, the event spotlighted the extraordinary contributions of individuals dedicated to improving the lives of those affected by celiac disease.

The Celiac Disease Foundation is pleased to share important research and clinical trial news from Anokion, a biotechnology company evaluating a treatment for celiac disease. Using our iQualifyCeliac screening platform,…

Joining research studies and clinical trials is the only way to help scientists better understand this autoimmune disease and ultimately find a cure for celiac disease. This spring, I joined one of those important trials, funded by the Foundation, to help researchers with the development of a revolutionary new screening tool for celiac disease.

Did you know that there are gluten-free summer camps that offer fun and peace of mind for children and teens with celiac disease? Learn about a few of the options available this summer!

We are pleased to share that the Medical Nutrition Therapy (MNT) Act of 2023 has been introduced in both the U.S. Senate and in the U.S. House of Representatives. Securing insurance coverage for registered dietitian nutritionist visits for celiac disease patients is a priority, and we are encouraged to see progress toward this goal.

A recent international study co-authored by Celiac Disease Foundation grant award winner Dr. Benjamin Lebwohl aimed to assess the effectiveness of the Pfizer COVID-19 vaccine in patients with celiac disease. Results revealed that the Pfizer COVID-19 vaccine offers the same level of protection against the virus for patients with celiac disease as it does for those without the autoimmune disease.

This October the Celiac Disease Foundation hosted physicians and healthcare representatives from more than 15 hospitals for a gluten-free meal to celebrate researchers and officers of NASPGHAN’s Celiac Special Interest Group and the important work they do through their care for our patient community.

The Celiac Disease Foundation is proud to continue our partnership with the Boston Children's Hospital in presenting "Celiac Smarts," a live-streamed symposium for the health care and celiac patient communities. Recording available now.